ArticleJournal of clinical medicine2025

Genetic Risk Profiling Reveals Altered Glycosyltransferase Expression as a Predictor for Patient Outcome in Neuroblastoma.

Isabelle Ariane Bley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.